Your session is about to expire
← Back to Search
Erenumab for Facial Pain
Study Summary
This trial will test whether Erenumab is effective at reducing midfacial pain or pressure in people without sinusitis.
- Facial Pain
- Sinusitis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many individuals are receiving treatment through this trial?
"Affirmative. Clinicaltrials.gov evidences that this clinical experiment, which was initially published on February 10th 2021, is actively searching for participants. Specifically, 66 patients must be recruited from 1 site to complete the study."
Has the FDA sanctioned Erenumab for use?
"There is substantial evidence for Erenumab's efficacy, thus it earned a rating of 3 on the safety scale."
Is recruitment still ongoing for this research endeavour?
"According to clinicaltrials.gov, this medical trial is actively seeking participants. The protocol was first uploaded on February 10th 2021 and underwent its final edit June 23rd 2022."
Does this medical experiment break new ground?
"Since 2019, Erenumab has been the subject of numerous clinical trials. Initially sponsored by Amgen, an initial 456-person study in 2019 gave way to Phase 3 approval and now there are 18 studies conducted across 179 cities worldwide over 32 countries."
Are there other documented attempts to utilize Erenumab in research?
"Presently, 18 clinical trials are underway exploring the efficacy of Erenumab with 3 currently in Phase 3. Rochester, Minnesota is home to some of these studies, but 549 different sites have joined the research effort."
Share this study with friends
Copy Link
Messenger